Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial (JAN, pvae009, 2024)

被引：0
|
作者：
Obayashi, Yuki
Natsuaki, Masahiro
Watanabe, Hirotoshi
Morimoto, Takeshi
Yamamoto, Ko
Nishikawa, Ryusuke
Ando, Kenji
Suwa, Satoru
Isawa, Tsuyoshi
Takenaka, Hiroyuki
Ishikawa, Tetsuya
Tokuyama, Hideo
Sakamoto, Hiroki
Fujita, Takanari
Nanasato, Mamoru
Okayama, Hideki
Nishikura, Tenjin
Kirigaya, Hidekuni
Nishida, Koji
Ono, Koh
Kimura, Takeshi
机构：
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2024年 / 10卷 / 05期
关键词：
D O I：
10.1093/ehjcvp/pvae046
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：478 / 478
页数：1
相关论文
共 50 条
  • [21] Complicated Percutaneous Coronary Intervention Strategy for a Patient with Heart Failure Secondary to Acute Coronary Syndrome
    Nakabayashi, Keisuke
    Kaneko, Nobuhito
    Ando, Hiroshi
    Shimizu, Minoru
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (15) : S78 - S79
  • [22] Risk Factors for Bleeding after Tirofiban in Elderly Patients with Acute Coronary Syndrome (ACS) Treated with Percutaneous Coronary Intervention
    Jia, H. D.
    Guo, Q. H.
    Song, T. T.
    Cong, H. L.
    Wang, Q. S.
    Chen, J.
    Cui, R.
    Liu, L.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S310 - S310
  • [23] Baseline anemia in patients undergoing percutaneous coronary intervention after an acute coronary syndrome-A paradox of high bleeding risk, high ischemic risk, and complex coronary disease
    Yazji, Khaled
    Abdul, Fairoz
    Elangovan, Senthil
    Ul Haq, Muhammad Z.
    Ossei-Gerning, Nick
    Morris, Keith
    Anderson, Richard
    Kinnaird, Tim
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2017, 30 (05) : 491 - 499
  • [24] Predictive Value of Free Triiodothyronine in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Yang, Zhi Qiang
    Ma, Xiao Teng
    Shao, Qiao Yu
    Li, Qiu Xuan
    Wang, Yu Fei
    Liang, Jing
    Shen, Hua
    Li Liu, Xiao
    Shi, Dong Mei
    Zhou, Yu Jie
    Fang, Zhe
    Wang, Zhi Jian
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (07)
  • [25] Troponin ratio and risk stratification in subjects with acute coronary syndrome undergoing percutaneous coronary intervention
    Brunetti, Natale Daniele
    Quagliara, Donato
    Di Biase, Matteo
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (06) : 435 - 442
  • [26] Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in high-bleeding-risk patients with acute coronary syndrome in contemporary practice
    Zhang, Yahao
    Zhang, Yanghui
    Liu, Zhiyu
    Zhang, Bin
    Liu, Guizhi
    Chen, Kui
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [27] Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?
    Lunardi, Mattia
    Onuma, Yoshinobu
    Serruys, Patrick W.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (27) : 2708 - 2709
  • [28] Predictive performance of different bleeding risk scores in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention
    Lyu, Si-Qi
    Zhu, Jun
    Wang, Juan
    Wu, Shuang
    Zhang, Han
    Shao, Xing-Hui
    Yang, Yan-Min
    [J]. PLATELETS, 2022, 33 (06) : 900 - 910
  • [29] Predictive performance of different bleeding risk scores in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention
    Lyu, S.
    Zhu, J.
    Yu, L.
    Yang, Y.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 566 - 566
  • [30] Percutaneous coronary intervention in acute coronary syndrome complicated by states Killip 3 and 4 in 2005
    E Zima
    G Szabo
    D Becker
    G Fulop
    L Geller
    L Molnar
    G Barczi
    S Toth
    A Horvath
    A Apor
    B Merkely
    [J]. Critical Care, 11 (Suppl 2):
12345